ABBV vs SMCI: Which Is the Better Buy?

Side-by-side comparison of AbbVie Inc. and Super Micro Computer, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
AbbVie Inc. ยท Healthcare
$261.70
-1.0% upside to fair value
Med Conviction Grade C High Quality
VS
Super Micro Computer, Inc. ยท Technology
$43.26
-4.2% upside to fair value
Med Conviction Grade C
QuantHub Verdict
ABBV has more upside to fair value (-1.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ABBV SMCI
Current Price $261.70 $43.26
Fair Value Estimate $259.04 $41.44
Upside to Fair Value -1.0% -4.2%
Market Cap $462.4B $28.0B
Forward P/E โ€” โ€”
EV / EBITDA 24.8x 8.9x
Price / Sales 7.2x 0.7x
Price / FCF 23.6x โ€”
Revenue Growth YoY +10.2% +93.2%
Gross Margin 71.5% 10.8%
Operating Margin 29.3% 7.1%
Return on Equity -136.5% 25.1%
Dividend Yield 2.61% 0%
FCF Yield 4.25% โ€”
Analyst Consensus Strong Buy Hold
Investment Thesis
ABBV โ€” AbbVie Inc.
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset aโ€ฆ
SMCI โ€” Super Micro Computer, Inc.
Super Micro Computer designs and sells modular, open-standard server and storage systems, with a growing franchise in liquid- and air-cooled AI racks such as the NVIDIA Vera Rubin NVL72, sold through direct, distribution and OEM channels to data center, cloud, AI, 5G and edge customers. The business quality is mixed: revenue grew 93.2% year over year and earnings grew 503.7% in the most recent quโ€ฆ
Accumulation Zones
Metric ABBV SMCI
Zone Low $194.28 $31.08
Zone High $220.18 $35.22
In Buy Zone? No No
โ† ABBV Research    SMCI Research โ†’    All Research